CSOP ETFs Weekly Performance Recap- 20231013

LCU's gains were primarily driven by Japan and China. Among individual firms, the notable gains were observed in Samsung Electronics and TSMC. Samsung Electronics recorded significant growth as its quarterly profit nearly tripled from the previous quarter, indicating signs of stabilization in the chip market. Meanwhile, TSMC witnessed a rise in its stock price driven by heightened demand from its six major customers, fueled by a media report indicating an expected increase of approximately 6% in the proportion of AI orders for 2024 compared to the current year, reaching a historic high.

SQQ/SQU’s gains were primarily led by Sea Ltd and Delta Electronics. Sea Ltd gained as its e-commerce arm, Shopee, has shown significant progress in Brazil, advancing from 5th place in 2022 to 2nd place in the latest survey. Meanwhile, Delta Electronics rose as KGI Securities analyst’s recommendation upgrade to outperform from neutral. 

SCY’s gains were largely attributable to gains in Chongqing Zhifei Biological Products following its announcement of an exclusive strategic vaccine partnership with GSK that will extend the availability of GSK’s shingles vaccine Shingrix in China and support possible future co-development and commercialization of GSK’s RSV vaccine Arexvy in China.  

Source: Bloomberg, as of 20231013.

“The investment product(s), as mentioned in this document, is/are registered under section 286 of the Securities and Futures Act (Cap. 289) of Singapore (the “SFA”).This material and the information contained in this material shall not be regarded as an offer or solicitation of business in any jurisdiction to any person to whom it is unlawful to offer or solicit business in such jurisdictions.

CSOP Asset Management Pte. Ltd. (“CSOP”) which prepared this document believes that information in this document is based upon sources that are believed to be accurate, complete, and reliable. However, CSOP does not warrant the accuracy and completeness of the information, and shall not be liable to the recipient or controlling shareholders of the recipient resulting from its use. CSOP is under no obligation to keep the information up-to-date. The provision of this document shall not be deemed as constituting any offer, acceptance, or promise of any further contract or amendment to any contract. The information herein shall not be disclosed, used or disseminated, in whole or part, and shall not be reproduced, copied or made available to others without the written consent of CSOP.

Advice should be sought from a financial adviser regarding the suitability of the investment and/or investment product before making an investment. Investment involves risk. The value of investments, and the income from them, can go down as well as up and an investor may get back less than the amount invested. Past performance is not necessarily indicative of future performance. Investor should read the prospectus and product highlights sheet, which can be obtained on CSOP website or authorized participating dealers, before deciding whether to invest. This document has not been reviewed by the Monetary Authority of Singapore.”